XBiotech (XBIT) Capital Expenditures (2014 - 2025)
XBiotech (XBIT) posted Capital Expenditures of $34,000 for Q4 2025, down 59.5% from $84,000 a year earlier and down 69.1% from the prior quarter.
Powered by 
Analysis
XBiotech (XBIT) Capital Expenditures (2014 - 2025) Analysis & Trends
For FY2025, XBiotech's Capital Expenditures came in at $289,000, down 77.8% from FY2024.
- Annual Capital Expenditures shows a five-year compound annual growth rate of -40.0% (FY2020 to FY2025).
- In prior years, XBiotech's Capital Expenditures was $1.3 million in FY2024 (+260.2%), $362,000 in FY2023 (-38.1%), $585,000 in FY2022 (-83.4%) and $3.53 million in FY2021 (-5.4%).
- The Q4 2025 figure stands as the lowest quarterly Capital Expenditures since Q3 2023.
- On a year-over-year basis, Capital Expenditures has declined in each of the last five quarters, with growth averaging 116.7% over the last seven quarters.
- The strongest year-over-year quarter for Capital Expenditures in the past five years was Q3 2024, with growth of 924.2%; the weakest was Q1 2023, with a decline of 96.3%.
- According to Business Quant data, Capital Expenditures for the three prior quarters was $110,000 (Q3 2025), $51,000 (Q2 2025) and $94,000 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 2.93 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 1.32 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 322.00 Mn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 893.00 Mn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 321.00 Mn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 1.86 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 513.00 Mn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 140.00 Mn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 533.00 Mn |
| 10 | XBiotech | 61.59 Mn | -473.83 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 34,000.00 |
| Sep 30, 2025 | 110,000.00 |
| Jun 30, 2025 | 51,000.00 |
| Mar 31, 2025 | 94,000.00 |
| Dec 31, 2024 | 84,000.00 |
| Sep 30, 2024 | 338,000.00 |
| Jun 30, 2024 | 627,000.00 |
| Mar 31, 2024 | 255,000.00 |
| Dec 31, 2023 | 115,000.00 |
| Sep 30, 2023 | 33,000.00 |
| Jun 30, 2023 | 208,000.00 |
| Mar 31, 2023 | 6,000.00 |
| Dec 31, 2022 | 132,000.00 |
| Sep 30, 2022 | 210,000.00 |
| Jun 30, 2022 | 82,000.00 |
| Mar 31, 2022 | 161,000.00 |
| Dec 31, 2021 | 476,000.00 |
| Sep 30, 2021 | 700,000.00 |
| Jun 30, 2021 | 1.71 Mn |
| Mar 31, 2021 | 637,000.00 |
API Access
XBiotech Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=XBIT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "XBIT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=XBIT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();